Notice NOT-OD-23-127 from the NIH Guide for Grants and Contracts

Notice NOT-HD-23-013 from the NIH Guide for Grants and Contracts

Applicants should have strong scientific communication skills and scientific integrity. We also seek candidates from broad areas (e.g., biophysics, biochemistry…
From Medical College of Wisconsin - Mon, 08 May 2023 03:13:01 GMT - View all Milwaukee, WI jobs

Ultimate Staffing: Ultimate Staffing is seeking a Bioinformatics Scientist to join a FAST-GROWING Medical Diagnostics Company in Irvine, CA! In this role, you will be... Irvine, California

Notice NOT-HL-23-070 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AI-23-024 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to enable early-stage research to better understand the underlying causes of radiation-associated sex differences to advance radiation preclinical animal models, improve MCM development, increase the safety and efficacy of MCMs, and advance biomarker science to assess radiation injuries.

Notice NOT-MH-23-310 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-126 from the NIH Guide for Grants and Contracts

Notice NOT-CA-23-065 from the NIH Guide for Grants and Contracts

Notice NOT-GM-23-042 from the NIH Guide for Grants and Contracts

Notice NOT-EB-23-007 from the NIH Guide for Grants and Contracts

Notice NOT-AG-23-015 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-114 from the NIH Guide for Grants and Contracts

Funding Opportunity PA-23-196 from the NIH Guide for Grants and Contracts. This announcement represents the continuation of an AHRQ program that provides support to individuals who are conducting research undertaken as part of an accredited academic program to qualify for a research doctorate degree.

£33,827 - £36,606: Animal and Plant Health Agency: PHA scientific activity focuses on protecting the UK against the threat of a wide variety of animal and zoonotic ..... Weybridge, Surrey

Funding Opportunity RFA-DK-23-012 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support a Human Liver Tissue and Hepatocytes Research Resource (HLTHRR) program to enable the continued availability of human liver tissue and hepatocytes to biomedical researchers. The research resource is expected to facilitate the procurement and preservation of human liver tissue and hepatocytesas well as the distribution of these materials to qualified biomedical researchers. Applications focused on animal liver and/or hepatocytes studies will not be considered responsive to this NOFO.

Notice NOT-TR-23-015 from the NIH Guide for Grants and Contracts

From £41,935 with benefits, subject to skills and experience.: The Francis Crick Institute: Postdoctoral Positions Join us at the Francis Crick Institute We are looking for scientists to join our community of more than 400 postdocs tacklin... London (Central), London (Greater) (GB)

Funding Opportunity RFA-NS-24-011 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) supports the development of PET radioligands that identify proteinopathies or pathological processes associated with the human biology of Alzheimer's disease related dementias (ADRDs). Activities supported under this FOA include, but are not limited to the in vitro screening of existing ligands against human ADRD brain tissue, medicinal chemistry support for development of new compounds and improvement of existing ligand specificity and selectivity, initial screening of ligands in appropriate animal models, and radioligand formulation and first-in-human testing. The Center without Walls should encompass research that will move promising ligands through in vitro and in vivo optimization to first-in-human studies. Applications must include an administrative core, a medicinal chemistry core, a clinical core, a scientific governance structure, and a minimum of two research projects with milestone plans that address workflows for screening of existing and newly derived ligands against human ADRD tissue and appropriate animal models. Synergy must be evident among Center research projects and cores, such that successful completion of the aims could not be accomplished without the Center structure. This FOA is in response to the Alzheimer's Disease Related Dementias (ADRD) challenges outlined in the 2016 update to the National Plan to Address Alzheimer's Disease.

Funding Opportunity RFA-OD-23-017 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity Announcement (NOFO) is to invite R01 applications to support biomedical and behavioral research that will provide scientific data to inform the regulation of tobacco products to protect public health. Research Projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP). The awards under this NOFO will be administered by NIH using funds that have been made available through FDA CTP and the Family Smoking Prevention and Tobacco Control Act (P.L. 111-31). Research results from this NOFO are expected to generate findings and data that are directly relevant to informing the FDA's regulation of the manufacture, distribution, and marketing of tobacco products to protect public health.